Cargando…
SARS CoV-2 seroprevalence in a US school district during COVID-19
Reduced symptomatology and access to testing in children have led to underestimates of paediatric COVID-19 prevalence and raised concerns about school safety. To explore COVID-19 prevalence and risk factors in school settings, we conducted a SARS-CoV-2 serosurvey in a Vermont, USA school district in...
Autores principales: | Bullis, Sean S M, Grebber, Benjamin, Cook, Sally, Graham, Nancy R, Carmolli, Marya, Dickson, Dorothy, Diehl, Sean A, Kirkpatrick, Beth D, Lee, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551743/ https://www.ncbi.nlm.nih.gov/pubmed/34725646 http://dx.doi.org/10.1136/bmjpo-2021-001259 |
Ejemplares similares
-
Oral rotavirus vaccine shedding as a marker of mucosal immunity
por: Lee, Benjamin, et al.
Publicado: (2021) -
Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children
por: Lee, Benjamin, et al.
Publicado: (2021) -
Association of breast milk gamma-linolenic acid with infant anthropometric outcomes in urban, low-income Bangladeshi families: a prospective, birth cohort study
por: Mychaleckyj, Josyf C., et al.
Publicado: (2019) -
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial
por: Crothers, Jessica W., et al.
Publicado: (2022) -
Corrigendum to “Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial” [Vaccine 40(19) (2022) 2705–2713]
por: Crothers, Jessica W., et al.
Publicado: (2022)